Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our high-tech, dedicated method is applied to construct targeted libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology leverages molecular simulations to examine a vast array of proteins, capturing their dynamics in both isolated forms and in complexes with other proteins. Through ensemble virtual screening, we thoroughly account for the protein's conformational mobility, identifying critical binding sites within functional regions and distant allosteric locations. This detailed exploration ensures that we comprehensively assess every possible mechanism of action, with the objective of identifying novel therapeutic targets and lead compounds that span a wide spectrum of biological functions.
Key features that set our library apart include:
partner
Reaxense
upacc
P07305
UPID:
H10_HUMAN
Alternative names:
Histone H1'; Histone H1(0)
Alternative UPACC:
P07305; B2R6I0; B4DRD6; Q6FG88; Q8N6R3
Background:
Histone H1.0, also known as Histone H1', plays a pivotal role in the condensation of nucleosome chains into higher-order structures. This process is crucial for the structural organization of chromatin in cells. Histone H1.0 is predominantly found in cells at terminal differentiation stages or those with low cell division rates, highlighting its importance in cell lifecycle regulation.
Therapeutic significance:
Understanding the role of Histone H1.0 could open doors to potential therapeutic strategies. Its involvement in chromatin structure regulation makes it a key player in cellular differentiation and proliferation processes, offering a novel angle for targeting diseases characterized by abnormal cell growth and differentiation.